Cristina Magdalena Muller

Title: Cristina Magdalena Muller: Innovator in Radiopharmaceuticals

Introduction

Cristina Magdalena Muller is a prominent inventor based in Nussbaumen, Switzerland. She has made significant contributions to the field of radiopharmaceuticals, holding a total of four patents. Her work focuses on innovative methods for diagnosing and monitoring various diseases, including cancer and autoimmune disorders.

Latest Patents

One of her latest patents is titled "F-saccharide-folates." This invention is directed towards new F-folate radiopharmaceuticals, wherein the F isotope is linked via a prosthetic group, specifically a saccharide group. This method allows for the covalent linking of the glutamate portion of a folate or its derivatives, enhancing the diagnosis and monitoring of cancer and inflammatory diseases. Another notable patent is "F-labelled folates as PET radiotracers." This invention involves the covalent linkage of fluorine-18 to the glutamate portion of a folate, facilitating the diagnosis and therapy monitoring of cancer and autoimmune diseases.

Career Highlights

Cristina works at Merck & Cie, a leading company in the pharmaceutical industry. Her innovative research and development efforts have positioned her as a key figure in her field. She has successfully translated her scientific knowledge into practical applications that benefit healthcare.

Collaborations

Cristina has collaborated with esteemed colleagues, including Roger Schibli and Rudolf Moser. These partnerships have further enhanced her research and contributed to the advancement of radiopharmaceutical technologies.

Conclusion

Cristina Magdalena Muller is a trailblazer in the field of radiopharmaceuticals, with a focus on innovative diagnostic methods. Her contributions are vital for the ongoing development of effective treatments for serious health conditions.